This article is free to access.
Cai, W., Cai, B., Zhou, J., Chen, Y., Zhang, J., Huang, Y., … Huang, J. (2019, October 11). Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: A retrospective study. Cancer Communications. BioMed Central Ltd. https://doi.org/10.1186/s40880-019-0405-5